Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study

Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study

Abstract Background The optimal dose and fractionation scheme of stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) remains unclear due to different tolerated liver volumes and degrees of cirrhosis. In this study, we aimed to verify the dose-survival relationship to optimi...

Full description

Bibliographic Details
Main Authors: Ting-Shi Su, Qiu-Hua Liu, Xiao-Fei Zhu, Ping Liang, Shi-Xiong Liang, Lin Lai, Ying Zhou, Yong Huang, Tao Cheng, Le-Qun Li
Format: Article
Language:English
Published: BMC 2021-04-01
Series:Radiation Oncology
Subjects:
Hepatocellular carcinoma
Radiotherapy dosage
Stereotactic body radiotherapy
Survival rate
Online Access:https://doi.org/10.1186/s13014-021-01778-6

Internet

https://doi.org/10.1186/s13014-021-01778-6

Similar Items